Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?S Brooks, S Kaur, B S Starr, et al.Pharmacology, Biochemistry, and Behavior|August 1, 1990
Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouseK Burke, C J Chandler, B S Starr, et al.Neuroscience|January 1, 1990
Motor depression: a new role for D1 receptors?C J Chandler, W Wohab, B S Starr, et al.European Journal of Pharmacology|March 28, 1996
NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated ratsC S Biggs, L J Fowler, P S Whitton, et al.Brain Research|July 3, 1995
Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysisC S Biggs, L J Fowler, P S Whitton, et al.Experimental Brain Research|January 1, 1980
Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studiesN K MacLeod, T A James, I C Kilpatrick, et al.Neuropharmacology|July 1, 1990
Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and ratG al-Tajir, C J Chandler, B S Starr, et al.Brain Research|April 4, 1997
Extracellular levels of glutamate and aspartate in the entopeduncular nucleus of the rat determined by microdialysis: regulation by striatal dopamine D2 receptors via the indirect striatal output pathway?C S Biggs, L J Fowler, P S Whitton, et al.Journal of Neurochemistry|April 1, 1992
Putative neurotoxicity of SKF 38393 and other D1 dopaminergic drugs investigated in rat striatumL Isaac, R Mills, L J Fowler, et al.Experimental Brain Research|January 1, 1980
Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioural and biochemical studiesI C Kilpatrick, M S Starr, A Fletcher, et al.Pageof 10